At IPO, Ergomed acquired sister company PrimeVigilance (PVL),a leading provider of drug safety (pharmacovigilance) and medical information services creating a broader service offering to healthcare companies. PrimeVigilance will continue to operate as an independent, specialised pharmacovigilance and medical information service provide.
PrimeVigilance, specialises in helping emerging and established companies to comply with post-marketing pharmacovigilance regulations and medical information services. Offering full pharmacovigilance services and specialist consulting its comprehensives covers all the regulatory, medical and scientific elements of PV required to obtain and maintain a product license within Europe, including:
- EU Qualified Person
- Detailed description of PV system
- Validated ARISg safety database
- Compliant PV system with robust Quality Management
- REMS and RMPs
- Medical Information services